The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy.
 
Nai-Jung Chiang
No Relationships to Disclose
 
Kun-Huei Yeh
No Relationships to Disclose
 
Chang-Fang Chiu
No Relationships to Disclose
 
Jen-Shi Chen
Research Funding - Merck Serono; Merck Serono (Inst); TTY Biopharm; TTY Biopharm (Inst)
 
Chueh-Chuan Yen
No Relationships to Disclose
 
Kuan-Der Lee
No Relationships to Disclose
 
Yu-Lin Lin
No Relationships to Disclose
 
Li-Yuan Bai
No Relationships to Disclose
 
Ming-Huang Chen
No Relationships to Disclose
 
Jen-Shi Lin
No Relationships to Disclose
 
Youngsen Yang
No Relationships to Disclose
 
Kun-Ming Rau
No Relationships to Disclose
 
Hui-Hua Hsiao
No Relationships to Disclose
 
Yan-Shen Shan
No Relationships to Disclose
 
Li-Tzong Chen
Research Funding - Merck Serono; Merck Serono (Inst); Merrimack; Merrimack (Inst); MSD; MSD (Inst); Novartis; Novartis (Inst); Ono Pharmaceutical; Ono Pharmaceutical (Inst); PharmaEngine; PharmaEngine (Inst); Sanofi; Sanofi (Inst); TTY Biopharm; TTY Biopharm (Inst)